We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+10.49%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$310B
AUM Growth
+$31.1B
Cap. Flow
+$9.23B
Cap. Flow %
2.98%
Top 10 Hldgs %
15.99%
Holding
3,632
New
124
Increased
2,654
Reduced
459
Closed
86

Sector Composition

Rank Sector Weight
1 Technology 19.49%
2 Financials 13.78%
3 Healthcare 13.39%
4 Industrials 9.54%
5 Consumer Discretionary 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNTH icon
3526
Dianthus Therapeutics
DNTH
$5.69B
$10.8K ﹤0.01%
1,711
EMKR
3527
DELISTED
Emcore Corp
EMKR
$10.7K ﹤0.01%
1,115
OGEN icon
3528
Oragenics
OGEN
$2.24M
$10.6K ﹤0.01%
56
BZFD icon
3529
BuzzFeed
BZFD
$99M
$10.3K ﹤0.01%
3,749
NCMI icon
3530
National CineMedia
NCMI
$378M
$10.2K ﹤0.01%
4,633
GLS
3531
DELISTED
Gelesis Holdings, Inc.
GLS
$10.2K ﹤0.01%
35,034
-16,733
-32% -$8.01K
SABS icon
3532
SAB Biotherapeutics
SABS
$266M
$9.58K ﹤0.01%
1,624
HEPA
3533
DELISTED
Hepion Pharmaceuticals
HEPA
$9.46K ﹤0.01%
32
SFT
3534
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$9.05K ﹤0.01%
6,078
FNCH
3535
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$9.02K ﹤0.01%
626
VIP
3536
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$35.4M
$8.13K ﹤0.01%
2,812
ORBS
3537
Eightco Holdings
ORBS
$225M
$7.73K ﹤0.01%
161
HALL
3538
DELISTED
Hallmark Financial Services, Inc.
HALL
$7.22K ﹤0.01%
1,236
BTCY
3539
DELISTED
Biotricity, Inc. Common Stock
BTCY
$7.21K ﹤0.01%
2,667
QNCX icon
3540
Quince Therapeutics
QNCX
$21.5M
$7.02K ﹤0.01%
55
TOVX icon
3541
Theriva Biologics
TOVX
$10.1M
$6.17K ﹤0.01%
543
AXLA
3542
DELISTED
Axcella Health Inc. Common Stock
AXLA
$5.98K ﹤0.01%
730
NBSE
3543
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$5.65K ﹤0.01%
1,486
RTB
3544
RTB Digital
RTB
$230M
$4.78K ﹤0.01%
30
MDVL
3545
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$3.56K ﹤0.01%
238
ABSI icon
3546
Absci
ABSI
$1.17B
-355,238
Closed -$1.11M
KEEL
3547
Keel Infrastructure Corp
KEEL
$1.92B
-92,625
Closed -$98K
CKPT
3548
DELISTED
Checkpoint Therapeutics
CKPT
-3,371
Closed -$36K
GLDM icon
3549
SPDR Gold MiniShares Trust
GLDM
$27.5B
-1,109,762
Closed -$36.6M
GROV icon
3550
Grove Collaborative
GROV
$45.8M
-3,468
Closed -$39K

Similar funds

Charles Schwab's Q4 2022 Portfolio in Review

As of Q4 2022, Charles Schwab held 3,632 positions worth $310B, up 11% from $279B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Charles Schwab's Q4 2022 filing shows 124 new, 2,654 increased, 459 reduced and 86 closed positions. Its largest new stake was iShares 0-5 Year TIPS Bond ETF: 4,612,793 shares worth $447M. The largest sale was Vanguard Intermediate-Term Treasury ETF, an estimated $738M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2022 buy was iShares 0-5 Year TIPS Bond ETF: 4,612,793 shares worth $447M.
  • Charles Schwab added most to iShares 7-10 Year Treasury Bond ETF in Q4 2022, an estimated $1.04B increase.
  • Charles Schwab's biggest Q4 2022 reduction was Vanguard Intermediate-Term Treasury ETF, cutting an estimated $738M.
  • Charles Schwab fully exited Duke Realty Corp. in Q4 2022, selling an estimated $175M.
  • Charles Schwab's ten largest holdings make up 16% of its $310B portfolio in Q4 2022.
  • Charles Schwab opened 124 new positions and closed 86 in Q4 2022.
  • Charles Schwab's portfolio value rose 11% quarter-over-quarter to $310B.

Based on Charles Schwab's 13F filing for Q4 2022, filed 13 Feb 2023.